Stocks gave up early gains to turn flat on Tuesday, weighed down by mixed corporate earnings and weaker-than-expected data on Midwest business activity and consumer confidence.
Stocks gave up early gains to turn flat on Tuesday, weighed down by mixed corporate earnings and weaker-than-expected data on Midwest business activity and consumer confidence.
Competition from low-cost generic drugs squeezed quarterly profits at Pfizer Inc. and Eli Lilly & Co. but the drugmakers were able to somewhat weather those declines with help from other medicines.
Pfizer remained profitable despite a reported drop in quarterly earnings, beating analysts' dire predictions of lost revenue to generic versions of its best-selling drug Lipitor through its non-pharmaceutical units and cost cutting.
Stock index futures pointed to a higher open on Tuesday, with sentiment improving on signs of progress in dealing with Europe's long-running sovereign debt crisis.
Stock index futures rose on Tuesday, with sentiment improving on signs of progress in dealing with Europe's long-running sovereign debt crisis.
Pfizer Inc
reported sharply lower quarterly earnings, hurt by generic forms of its Lipitor cholesterol drug, and the company trimmed its 2012 forecasts because of negative effects of the stronger dollar.Stock index futures pointed to a higher open on Wall Street on Tuesday, with futures for the S&P 500, the Dow Jones and Nasdaq 100 indexes up 0.5-0.6 percent.
The world's major pharmaceutical companies joined forces with governments and leading global health organizations Monday to donate drugs and scientific know-how to help control or wipe out 10 neglected tropical diseases by 2020.
January has turned out to be strong for stocks with just two trading days to go. If you're afraid to miss the ride, there's still time to jump in. You just might want to wear a neck brace.
January has turned out strong for equities with just two trading days to go. If you're afraid to miss the ride, there's still time to jump in. You just might want to wear a neck brace.
The U.S. government has set a deadline of 2025 for finding an effective way to treat or prevent Alzheimer's disease, an ambitious target considering there is no cure on the horizon and one that sets a firm deadline unlike previous campaigns against cancer or AIDS.
Wikipedia's blackout Wednesday in protest against the controversial SOPA and PIPA shocked and affected people who strive for free and open knowledge online. However, the blackout didn't affect the traffic to Wikipedia as the gawkers clicked the site so many times that the Web site saw an unexpected boost in traffic.
Chinese legends have long extolled the benefits of the Tian Shan Xue Lian, a rare white flower found in snowcapped mountains that is revered as a panacea, an elixir so powerful it can supposedly bring the dead back to life.
Novartis Consumer Health Inc. on Sunday, voluntarily recalled Excedrin and NoDoz products in the United States because they may contain some stray tablets, capsules caplets from other Novartis products. There may also be some broken or chipped tablets inside the packages.
Alibaba Group has hired a Washington lobbying firm in a sign that the Chinese e-commerce company would be willing to make a bid for all of Yahoo Inc. in the event that talks to unwind their Asian partnership fail.
China Mengniu Dairy Co Ltd, the nation's biggest dairy firm, said it had destroyed milk found to be contaminated with a cancer-causing substance, the latest food safety problem to hit the country's dairy industry.
Pfizer Inc
, the world's biggest drugmaker, named Chief Executive Ian Read to the additional post of chairman and authorized buying back company stock for up to $10 billion.Pfizer Inc
, the world's biggest drugmaker, on Monday authorized up to $10 billion worth of additional stock repurchases and raised its quarterly dividend by 10 percent.Shares of Pfizer (NSYE: PFE) were trading Monday after the news down 1.17 percent, or 23 cents, to $20.32 at 3 p.m. Eastern Time. The stock was among the most actively traded on the NYSE. But the market as a whole was trading down on concerns that the latest Eurozone plan won't help the continent avert financial crisis.
A new study of leukemia drug Mylotarg, pulled from the U.S. market last year due to safety concerns, found it to be effective when used at low doses in older adults but questions about toxicity remain.
As unprecedented conditions continue to buffet the U.S. equities, and investors pull tens of billions out, investment managers are increasingly counseling their clients on what could be the most basic of stock market strategies: put your cash in mature high-dividend shares of mature companies, and stop fussing.
